{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:17:37Z","timestamp":1780431457228,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["234223"],"award-info":[{"award-number":["234223"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health, National Institute of Neurological Disorders and Stroke","award":["R01 NS064059"],"award-info":[{"award-number":["R01 NS064059"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jneuroim.2015.10.023","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T02:56:42Z","timestamp":1446605802000},"page":"130-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["IL-10 derived from CD1dhiCD5+ B cells regulates experimental autoimmune myasthenia gravis"],"prefix":"10.1016","volume":"289","author":[{"given":"Jian Rong","family":"Sheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhua","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Soliven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.10.023_bb0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/jaut.1996.0036","article-title":"The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes","volume":"9","author":"Balasa","year":"1996","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0065-2776(08)60876-7","article-title":"Human B lymphocytes: phenotype, proliferation, and differentiation","volume":"52","author":"Banchereau","year":"1992","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0015","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","article-title":"IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice","volume":"161","author":"Bettelli","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/imr.12176","article-title":"B10 cell regulation of health and disease","volume":"259","author":"Candando","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0025","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clim.1999.4807","article-title":"Animal models of myasthenia gravis","volume":"94","author":"Christadoss","year":"2000","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0030","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.189.6.1005","article-title":"Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis","volume":"189","author":"Cua","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199406233302507","article-title":"Myasthenia gravis","volume":"330","author":"Drachman","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0040","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.43.7.601","article-title":"Mechanisms of acetylcholine receptor loss in myasthenia gravis","volume":"43","author":"Drachman","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2004.03.017","article-title":"Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells","volume":"16","author":"Duan","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0050","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0055","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13075-014-0419-y","article-title":"Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction","volume":"16","author":"Greenhill","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0060","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4049\/jimmunol.1201427","article-title":"Regulatory B cell (B10 cell) expansion during Listeria infection governs innate and cellular immune responses in mice","volume":"190","author":"Horikawa","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0167-5699(92)90153-X","article-title":"Biological properties of interleukin 10","volume":"13","author":"Howard","year":"1992","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00918147","article-title":"Biological properties of interleukin 10","volume":"12","author":"Howard","year":"1992","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0075","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2249.1999.01062.x","article-title":"Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG)","volume":"118","author":"Huang","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2015.10.023_bb0085","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar3907","article-title":"IL-10-producing regulatory B cells (B10 cells) in autoimmune disease","volume":"15","author":"Kalampokis","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/MIB.0000000000000468","article-title":"A multihit model: colitis lessons from the interleukin-10-deficient mouse","author":"Keubler","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)63052-9","article-title":"Interleukin-10: biology, role in inflammation and autoimmunity","volume":"79","author":"Lalani","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0100","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.4049\/jimmunol.1300649","article-title":"Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice","volume":"191","author":"Maseda","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0105","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0110","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","article-title":"Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis","volume":"185","author":"Matsushita","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0115","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0125","doi-asserted-by":"crossref","first-page":"A49","DOI":"10.1016\/S0167-5699(05)80015-5","article-title":"The role of IL-10 in crossregulation of TH1 and TH2 responses","volume":"12","author":"Mosmann","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0130","first-page":"57","article-title":"Immunomodulation of Crohn's disease by interleukin-10","volume":"49","author":"Narula","year":"1998","journal-title":"Agents Actions Suppl."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0135","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.166.8.4853","article-title":"Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis","volume":"166","author":"Ostlie","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0165-5728(00)00385-4","article-title":"Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR","volume":"111","author":"Poussin","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jlb.61.4.389","article-title":"Studies with IL-10\u2212\/\u2212 mice: an overview","volume":"61","author":"Rennick","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0150","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/intimm\/10.6.807","article-title":"IL-10 has a protective role in experimental autoimmune uveoretinitis","volume":"10","author":"Rizzo","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0155","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/eji.1830240629","article-title":"Interleukin-10 prevents experimental allergic encephalomyelitis in rats","volume":"24","author":"Rott","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/cimm.1998.1365","article-title":"Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery","volume":"188","author":"Samoilova","year":"1998","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0165","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.187.4.537","article-title":"An interleukin (IL)-10\/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease","volume":"187","author":"Segal","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0170","doi-asserted-by":"crossref","unstructured":"Sheng, J. R., Li, L., Ganesh, B. B., Vasu, C., Prabhakar, B. S. & Meriggioli, M. N. 2006. Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J. Immunol., 177, 5296\u2013306.","DOI":"10.4049\/jimmunol.177.8.5296"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0175","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clim.2008.03.509","article-title":"Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis","volume":"128","author":"Sheng","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0180","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jneuroim.2011.10.010","article-title":"GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental myasthenia gravis","volume":"240\u2013241","author":"Sheng","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0185","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.4049\/jimmunol.1303397","article-title":"CD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis","volume":"193","author":"Sheng","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0190","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0195","doi-asserted-by":"crossref","unstructured":"Vincent, A. 2002. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol., 2, 797\u2013804.","DOI":"10.1038\/nri916"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0200","first-page":"159","article-title":"Myasthenia gravis","volume":"88","author":"Vincent","year":"2002","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0205","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/intimm\/12.10.1381","article-title":"Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravis","volume":"12","author":"Wang","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0210","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0215","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0220","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.ajpath.2012.03.010","article-title":"IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation","volume":"180","author":"Yang","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0225","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2009.02729.x","article-title":"Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis","volume":"16","author":"Yeh","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/08916934.2014.992517","article-title":"B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis","volume":"48","author":"Yilmaz","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0235","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(00)00411-2","article-title":"Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR","volume":"113","author":"Zhang","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2015.10.023_bb0245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/08820139.2014.917096","article-title":"Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis","volume":"43","author":"Zheng","year":"2014","journal-title":"Immunol. Investig."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815300679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:26:20Z","timestamp":1759047980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815300679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":49,"alternative-id":["S0165572815300679"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.023","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-10 derived from CD1dhiCD5+ B cells regulates experimental autoimmune myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}